RxDoctor Payments Data

Jeffrey Lynch, DO

Orthopaedic Surgery · Wilmington, DENPI 1063073765

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $6,235 of the $10,376 with a category attached, or 60.1%. Encore Medical, LP accounts for 61.3% of it on its own, with 7 other manufacturers making up the rest.

$10,376in general payments, 2019–2025

Across 33 payments — averaging $314.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$6K
  • Stryker$2K
  • Arthrex$708
  • Eclipse Technology Solutions Inc.$335
  • Zimmer Biomet$287
  • Johnson & Johnson$156
  • plus $56 from 2 others

What the payments were for

  • Consulting fees$1,50014%
  • Travel & lodging$6,23560%
  • Food & beverage$1,48814%
  • Education$1,15311%

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Encore Medical, LP12$6,357
Stryker8$2,477
Arthrex1$708
Eclipse Technology Solutions Inc.6$335
Zimmer Biomet2$287
Johnson & Johnson2$156
Catalyst Orthoscience1$29
Nexus Medical Technologies LLC1$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,376 in reported general payments places this provider in the 65th percentile of 70 orthopaedic surgery providers in Delaware.

See all orthopaedic surgery providers in Delaware

Medicare billing

Part B allowed, 2024
$8,651
Medicare patients
29
Services billed
39

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl23$113

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Wilmington

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →